Europe's most important breast cancer meeting, the 3rd European Breast Cancer Conference

February 22, 2002

Second media alert

Europe's most important breast cancer conference is taking place soon in Barcelona

3rd European Breast Cancer Conference (EBCC-3)
Palau de Congressos de Catalunya, Barcelona, Spain
19-23 March 2002


About EBCC-3...
- More than 3000 clinicians, scientists and patient advocates will attend.
- Presentations will review new developments in molecular biology, epidemiology, prevention, diagnosis, treatment, psycho-social implications of breast cancer and quality of life aspects, the role of patient advocates and breast cancer support groups.
- Daily media briefings in English will focus on new research findings and also include controversial issues such as screening, and the Europe-wide threat to the future of breast cancer research. Briefings in Spanish will also be held.
-Cristina Hoyos, famous Spanish flamenco dancer, breast cancer survivor and advocate, will receive the Nathwani Prize during the Opening Ceremony. This prize is conferred to a person who demonstrated commitment to the humanities in breast cancer research, treatment or advocacy.
- Spanish opera singer José Carreras will offer a special recital on the occasion of EBCC-3 with benefits to go to cancer projects.

To find more details of the programme...
Visit the Federation of European Cancer Societies (FECS) website:
http://www.fecs.be/Conferences/ebcc3/index.shtml

Free media registration - on provision of bona fide press credentials
All bona fide media representatives receive free registration.
To register now: complete the attached form or register on the FECS website:
http://www.fecs.be/conferences/ebcc3/media.shtml At EBCC-3: registration will be available as of 19 March 2002, on production of appropriate credentials.

Assisting you in Lisbon...
-Comprehensive media facilities including a fully equipped media center will be available on-site.
-Opportunities for interviews with leading international speakers.
-Daily media briefings in English and two in Spanish. Briefings will take place in Palau de Congressos de Catalunya (Room A, Level -1).


BRIEFINGS IN SPANISH:

Tuesday 19 March (11:30-12:30)

Chair: Dr José Baselga
Dr José Baselga - breast cancer - where we are now. Highlights of EBCC-3
Mrs. Cristina Hoyos - The personal fight against cancer of this famous Spanish flamenco dancer who will receive the Nathwani Prize for her role as a breast cancer activist
Mrs Ana Fernandez Marcos - The psycho-social implications of breast cancer. The role of advocacy groups such as Europa Donna.

Tuesday 19 March (14:00-14:30)

Dr Rafael Salvador - Spain's screening programme

BRIEFINGS IN ENGLISH:

Tuesday 19 March (13:15 - 14:00)

Special screening briefing - the controversy continues......

Chair: Dr Rafael Salvador
Dr Robin Wilson - screening - where we are now
Dr Rafael Salvador - Spain goes ahead
Dr Chris de Wolf - Switzerland holds back
Wednesday 20 March (13:15 - 14:15)

Chair: Dr José Baselga
Prof Jack Cuzick - prevention studies - new findings
Prof Mitch Dowsett - latest data on new endocrine agents
Dr Dana Leach - novel human DNA HER2 vaccine moves into patient trials
Mr Andrew Lee - lasers and sentinel nodes - study identifies novel way to detect cancer spread in lymph nodes
Thursday 21 March (13:15 -14:15)

Chair: Prof Felipe Calvo
Prof Peter Boyle - changing breast cancer trends - is it lifestyle and environment?
Dr Stephen Johnston - inhibiting enzymes in breast cancer - latest findings on novel targeted drugs
Dr Emiel Rutgers - intraoperative radiotherapy to control breast cancer - new results show promise for avoiding traditional radiotherapy
Dr Laura van 't Veer - results from novel microarray study - how to select patients for adjuvant therapy and prevent overtreatment

Friday 22 March (13:15 - 14:15)

Chair: Prof Michael Baum
Dr Ann McPherson - DIPEx- the world's first database of individual patient experiences
Dr Ashutosh Kothari - breast duct micro-endoscopy - new tool for breast cancer diagnosis?
Mrs Maartje Hooning - long-term risk of second cancers after breast cancer treatment - new results from 3,900 patients
Prof Michael Baum & Dr Martine Piccart - the threat to breast cancer research

Languages
- Media center staff speaking English, Spanish and French.
-Press packs with the latest figures and research.
- EBCC-3 is held in English.

Accommodation
For hotel accommodation please contact:
Viajes Iberia Congresos
C/Fontanella, 21-23 4° 1a
E-08010 Barcelona
Spain
Tel +34 (93) 5101005
Fax +34 (93) 5101009
e-mail: congresos.barcelona@viajesiberia.com

If you are unable to attend EBCC-3
If you are unable to attend this important congress, a number of opportunities to report on the proceedings will exist.
- Daily news digests will be issued on the website
- Opportunities for telephone interviews with selected speakers
- You can request daily news by fax or e-mail

To receive additional information...
Return the registration form

Further information?
Please contact Maria Maneiro at FECS, Maria@fecs.be or tel. +32-2-7750207

ECCO-the European CanCer Organisation

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.